Apollomics Inc. is an innovative biotechnology firm focused on revolutionizing cancer treatment through the discovery and development of both mono and combination therapies that leverage the immune system and target key molecular pathways. Headquartered in Foster City, California, with additional facilities in Hangzhou and Shanghai, China, along with Southbank, Australia, the company is strategically positioned to advance its clinical programs in oncology. Apollomics aims to improve therapeutic outcomes for patients by addressing unmet needs in cancer care through its cutting-edge research and development efforts.